Induction Therapy for Thymic Malignancies

Avedis Meneshian, Stephen C. Yang

Research output: Contribution to journalReview articlepeer-review


Thymic malignancies are rare tumors of the chest that express a broad range of biological behaviors. Surgery remains the mainstay of therapy, and complete surgical resection is the primary predictor of long-term survival. Although there is a paucity of clinical trials assessing the role of induction/adjuvant chemotherapy and/or radiation therapy in the treatment of thymic malignancies, existing data suggest that induction therapy should be offered for the treatment of advanced-stage disease, and postoperative radiation for specific stages.

Original languageEnglish (US)
Pages (from-to)83-89
Number of pages7
JournalThoracic surgery clinics
Issue number1
StatePublished - Feb 2012


  • Induction therapy
  • Neoadjuvant therapy
  • Thymic carcinoma
  • Thymoma

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Induction Therapy for Thymic Malignancies'. Together they form a unique fingerprint.

Cite this